Related Experiment Video
Updated: Apr 19, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
New frontiers and clinical applications for botulinum neuromodulators
Jared Jagdeo1, Alastair Carruthers, Kevin C Smith
1Department of Dermatology, UC Davis Medical Center, Sacramento, California, Dermatology Service, Sacramento VA Medical Center, Mather, California, Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada Private Practice, Niagara Falls, Ontario, Canada.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...

